Literature DB >> 24993486

Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions.

Heidi E Jones1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24993486     DOI： 10.1016/j.contraception.2014.05.014

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  7 in total

1.  Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.

Authors:  Kristin M Wall; William Kilembe; Bellington Vwalika; Naw Htee Khu; Ilene Brill; Elwyn Chomba; Brent A Johnson; Lisa Haddad; Amanda Tichacek; Susan Allen
Journal:  Contraception       Date:  2015-02-21       Impact factor: 3.375

2.  Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.

Authors:  Lauren J Ralph; Sandra I McCoy; Karen Shiu; Nancy S Padian
Journal:  Lancet Infect Dis       Date:  2015-01-09       Impact factor: 25.071

3.  Broadening the debate over HIV and hormonal contraception.

Authors:  Christopher J Colvin; Abigail Harrison
Journal:  Lancet Infect Dis       Date:  2015-01-09       Impact factor: 25.071

4.  Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity.

Authors:  Xiangxu Jia; Qiujia Shao; Ahsen R Chaudhry; Ballington L Kinlock; Michael G Izban; Hong-Ying Zhang; Fernando Villalta; James E K Hildreth; Bindong Liu
Journal:  Pathogens       Date:  2021-09-14

5.  The Need for Policy Change Regarding Progestin-Only Injectable Contraceptives.

Authors:  Erica L Gollub; Heidi E Jones; Lauren J Ralph; Janneke H H M van de Wijgert; Nancy Padian; Zena Stein
Journal:  J Womens Health (Larchmt)       Date:  2018-12-21       Impact factor: 3.017

6.  Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study).

Authors:  G Justus Hofmeyr; Charles S Morrison; Jared M Baeten; Tsungai Chipato; Deborah Donnell; Peter Gichangi; Nelly Mugo; Kavita Nanda; Helen Rees; Petrus Steyn; Douglas Taylor
Journal:  Gates Open Res       Date:  2018-03-13

7.  Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.

Authors:  Janet P Hapgood
Journal:  AIDS Res Hum Retroviruses       Date:  2020-01-22       Impact factor: 2.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.